ArticleScientific reports2025
Anatomy guided modality fusion for cancer segmentation in PET CT volumes and images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Segmentation in computed tomography (CT) provides detailed anatomical information, while positron emission tomography (PET) provide the metabolic activity of cancer. Existing segmentation models in CT and PET either rely on early fusion, which struggles to effectively capture independent features from each modality, or late fusion, which is computationally expensive and fails to leverage the complementary nature of the two modalities. This research addresses the gap by proposing an intermediate fusion approach that optimally balances the strengths of both modalities. Our method leverages anatomical features to guide the fusion process while preserving spatial representation quality. We achieve this through the separate encoding of anatomical and metabolic features followed by an attentive fusion decoder. Unlike traditional fixed normalization techniques, we introduce novel "zero layers" with learnable normalization. The proposed intermediate fusion reduces the number of filters, resulting in a lightweight model. Our approach demonstrates superior performance, achieving a dice score of 0.8184 and an [Formula: see text] score of 2.31. The implications of this study include more precise tumor delineation, leading to enhanced cancer diagnosis and more effective treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.